TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

BETAMETHASONE VALERATE

BETAMETHASONE VALERATE
Approved 1983-08-31
Jump to: Indications Approvals Trials Competitors Safety Patents
10
Indications
--
Phase 3 Trials
42
Years on Market

Details

Status
Discontinued
First Approved
1983-08-31
Routes
TOPICAL
Dosage Forms
LOTION, OINTMENT, AEROSOL, FOAM, CREAM

Companies

PHARMADERM PERRIGO NEW YORK Teva PADAGIS ISRAEL XIROMED PHARMAFAIR FOUGERA PHARMS INC INGENUS PHARMS LLC ALEMBIC SENORES PHARMS TARO SUN PHARMA CANADA
Active Ingredient: BETAMETHASONE VALERATE

BETAMETHASONE VALERATE Approval History

Loading approval history...

What BETAMETHASONE VALERATE Treats

10 FDA approvals

Originally approved for its first indication in 1983 . Covers 10 distinct patient populations.

  • Other (10)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

BETAMETHASONE VALERATE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA018870 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.